Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Retained Earnings (2016 - 2025)

Historic Retained Earnings for Harvard Bioscience (HBIO) over the last 17 years, with Q3 2025 value amounting to -$211.9 million.

  • Harvard Bioscience's Retained Earnings fell 3406.67% to -$211.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$211.9 million, marking a year-over-year decrease of 3406.67%. This contributed to the annual value of -$158.0 million for FY2024, which is 851.96% down from last year.
  • Harvard Bioscience's Retained Earnings amounted to -$211.9 million in Q3 2025, which was down 3406.67% from -$210.6 million recorded in Q2 2025.
  • In the past 5 years, Harvard Bioscience's Retained Earnings ranged from a high of -$132.7 million in Q4 2021 and a low of -$211.9 million during Q3 2025
  • In the last 5 years, Harvard Bioscience's Retained Earnings had a median value of -$142.5 million in 2023 and averaged -$153.5 million.
  • Per our database at Business Quant, Harvard Bioscience's Retained Earnings decreased by 21.75% in 2021 and then plummeted by 3862.37% in 2025.
  • Over the past 5 years, Harvard Bioscience's Retained Earnings (Quarter) stood at -$132.7 million in 2021, then decreased by 7.17% to -$142.2 million in 2022, then dropped by 2.4% to -$145.6 million in 2023, then dropped by 8.52% to -$158.0 million in 2024, then crashed by 34.08% to -$211.9 million in 2025.
  • Its last three reported values are -$211.9 million in Q3 2025, -$210.6 million for Q2 2025, and -$208.4 million during Q1 2025.